Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13243865 | 0.77 | CYP2D6 (0.67) | DPP4CYP2D6TAAR1SLC6A2MAOA | |
| SCHEMBL13243866 | 0.77 | CYP2D6 (0.67) | DPP4CYP2D6TAAR1SLC6A2MAOA | |
| SCHEMBL13243863 | 0.77 | CYP2D6 (0.67) | DPP4CYP2D6TAAR1SLC6A2MAOA | |
| SCHEMBL9054723 | 0.77 | GRIN2D (0.47) | DPP4TAAR1 | |
| SCHEMBL13243599 | 0.77 | CYP2D6 (0.67) | DPP4CYP2D6TAAR1SLC6A2MAOA | |
| SCHEMBL1724429 | 0.77 | SLC6A2 (0.52) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL9582478 | 0.76 | GRIN2D (0.46) | DPP4 | |
| SCHEMBL9001661 | 0.75 | ALDH1A1 (0.42) | TAAR1SIGMAR1 | |
| SCHEMBL270111 | 0.74 | GABRA1 (0.52) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL9001659 | 0.74 | ALDH1A1 (0.41) | TAAR1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 698 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4902707-A | Bicyclic pyrazolidinones, compositions and use | ELI LILLY AND COMPANY (US) | 1990-02-20 | — | — | US | claimed |
| EP-4727917-A1 | BIODEGRADABLE CARBAMATE LIPIDS WITH INCREASED STABILITY | Ramot at Tel-Aviv University Ltd. (IL) | 2026-04-22 | — | — | EP | disclosed |
| US-20260102386-A1 | USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS | VIDAC PHARMA LTD. (IL) | 2026-04-16 | — | — | US | disclosed |
| EP-4096656-B1 | NOVEL ACTIVATORS OF THE LIPIDATING TRANSPORTER ATP BINDING CASSETTE PROTEIN TYPE 1 (ABCA1) AND THERAPEUTIC USES THEREOF | UNIV RAMOT (IL) | 2026-01-28 | — | — | EP | disclosed |
| US-12527782-B2 | Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers | VIDAC PHARMA LTD. (IL) | 2026-01-20 | — | — | US | disclosed |
| US-20250387417-A1 | CANNABINOID DERIVATIVES AND COMPOSITIONS COMPRISING SAME | CANNASOUL ANALYTICS LTD (IL) | 2025-12-25 | — | — | US | disclosed |
| EP-3750530-B1 | COMBINATIONS OF IRS/STAT3 DUAL MODULATORS AND ANTI-CANCER AGENTS FOR TREATING CANCER | TYRNOVO LTD (IL) | 2025-12-24 | — | — | EP | disclosed |
| WO-2025228979-A1 | LIPIDS NANOPARTICLE FORMULATIONS SUITABLE FOR LUNG TARGETING | NEOVAC LTD. (GB) | 2025-11-06 | — | — | WO | disclosed |
| US-20250236578-A1 | NOVEL CANNABINOID DERIVATIVES | CANNASOUL ANALYTICS LTD. (IL) | 2025-07-24 | — | — | US | disclosed |
| US-20250162978-A1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | UNIV RAMOT (IL) | 2025-05-22 | — | — | US | disclosed |
| US-4072754-A | ANTICHOLESTEROL | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-02-07 | — | — | US | disclosed |
| US-4069338-A | INDOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-01-17 | — | — | US | disclosed |
| US-4057647-A | Araliphatic dihalogen compounds and process for their preparation | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-11-08 | — | — | US | disclosed |
| US-4051170-A | Diphenoxyacetic acid derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-09-27 | — | — | US | disclosed |
| US-4051250-A | OXAZOLE, THIAZOLE | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-09-27 | — | — | US | disclosed |
| US-4049823-A | Phenylbutanol derivatives and compositions containing them | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-09-20 | — | — | US | disclosed |
| US-4039536-A | 7-(α-SUBSTITUTED GLYCINAMIDO)-3-SUBSTITUTED METHYL-3-CEPHEM-4-CARBOXYLIC ACIDS AND THEIR DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1977-08-02 | — | — | US | disclosed |
| US-3992386-A | 4(Quinolyl)phenoxy alkanoic acid derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-11-16 | — | — | US | disclosed |
| US-3933840-A | ANTIPHLOGISTIC | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-01-20 | — | — | US | disclosed |
| US-3932487-A | HYPOTENSIVE | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250236578-A1 | NOVEL CANNABINOID DERIVATIVES | CNR2, CNR1, FAAH | DPP4 2591/4885CYP2D6 417/4885TAAR1 859/4885 |
| US-20250162978-A1 | CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF | NPC1L1, NPC1, CETP | DPP4 2334/4885CYP2D6 4339/4885TAAR1 4025/4885 |
| US-20250387417-A1 | CANNABINOID DERIVATIVES AND COMPOSITIONS COMPRISING SAME | CNR1, CNR2, OPRM1 | DPP4 2224/4885CYP2D6 128/4885TAAR1 1344/4885 |
| US-12527782-B2 | Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers | HK2, HK1, AK2 | DPP4 2495/4885CYP2D6 1047/4885TAAR1 4828/4885 |
| US-20260102386-A1 | USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS | HK2, HK1, AK2 | DPP4 2684/4885CYP2D6 699/4885TAAR1 4464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.